Drugs / Sheng Mai Capsules
Sheng Mai Capsules
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| — | NCT00817024 Comparator | Mar 2008 → Mar 2009 | coronary artery disorder | Guang'anmen Hospital of China Academy of Chinese Medical Sciences | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Sheng Mai Capsules | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00817024 ↗ |
| Known as | Shengmai Capsule | “Compared with Shengmai Capsule (生脉胶囊, SM), the study was conducted to evaluate the efficacy and safety of Xuefu Zhuyu Capsule (血府逐瘀胶囊, XFZY) on the symptoms and signs and...” PMID 20535581 ↗ Jun 2010 |
| Known as | 生脉胶囊 | “Compared with Shengmai Capsule (生脉胶囊, SM), the study was conducted to evaluate the efficacy and safety of Xuefu Zhuyu Capsule (血府逐瘀胶囊, XFZY) on the symptoms and signs and...” PMID 20535581 ↗ Jun 2010 |